SARS-CoV-2 infection is relatively frequent in the elderly with co-morbidities (metabolic, cardiovascular, neoplastic, brain disorders) in whom low ACE2 levels may reduce the potential risk of COVID-19 [214]. This evidence concerns the gene ACE2 and COVID-19.